ContraFect

ContraFect Free Cash Flow

The Free Cash Flow (FCF) of ContraFect (CFRXQ) as of Oct 19, 2026 is -46.03 M USD. In the previous year, Free Cash Flow (FCF) was -41.13 M USD — a change of 11.91% (lower).

Free Cash Flow

-46.03 MUSD

YoY

11.91%

Last updated:

Free Cash Flow (FCF) of ContraFect is 2022 -46.03 M USD. Free Cash Flow (FCF) of ContraFect was 2021 -41.13 M USD. It decreases by 11.91% lower compared to the previous year.

The ContraFect Free Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Free Cash Flow
Date
Free Cash Flow
Jan 1, 2015
-22.19 M USD
Jan 1, 2016
-29.41 M USD
Jan 1, 2017
-24.53 M USD
Jan 1, 2018
-26.39 M USD
Jan 1, 2019
-27.45 M USD
Jan 1, 2020
-33.19 M USD
Jan 1, 2021
-41.13 M USD
Jan 1, 2022
-46.03 M USD
The ContraFect Free Cash Flow history
YEARFree Cash FlowYoY
-46.03 MUSD+11.91%
-41.13 MUSD+23.92%
-33.19 MUSD+20.91%
-27.45 MUSD+4.02%
-26.39 MUSD+7.58%
-24.53 MUSD-16.59%
-29.41 MUSD+32.54%
-22.19 MUSD+49.33%
-14.86 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ContraFect Stock analysis

What does ContraFect do? ContraFect Corp, based in Yonkers, New York, is a clinical-stage biotechnology company focused on developing direct lytic agents (DLAs) such as lysins and amurin peptides to treat life-threatening antibiotic-resistant infections. The company, listed in 2014, employs 23 people and is advancing its lead candidate exebacase (CF-301) for MRSA bloodstream infections and chronic prosthetic joint infections, alongside CF-370 targeting gram-negative bacteria. ContraFect is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ContraFect stock

Free Cash Flow (FCF) of ContraFect is -46.03 M USD in 2022.

Free Cash Flow (FCF) of ContraFect changed from -41.13 M USD to -46.03 M USD, representing a 11.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow (FCF) ContraFect since 2006 – with annual values, charts, and detailed analysis.

Free Cash Flow is the cash available after capital expenditures. It represents the cash a company can use for dividends, debt reduction, or reinvestment.

FCF = Operating Cash Flow - Capital Expenditures

Free Cash Flow (FCF)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Free Cash Flow (FCF)'s ContraFect historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ContraFect

All Key Metrics — ContraFect